BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37899131)

  • 1. Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery.
    Zhang B; Bassani-Sternberg M
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOF
    Hoenisch Gravel N; Nelde A; Bauer J; Mühlenbruch L; Schroeder SM; Neidert MC; Scheid J; Lemke S; Dubbelaar ML; Wacker M; Dengler A; Klein R; Mauz PS; Löwenheim H; Hauri-Hohl M; Martin R; Hennenlotter J; Stenzl A; Heitmann JS; Salih HR; Rammensee HG; Walz JS
    Nat Commun; 2023 Nov; 14(1):7472. PubMed ID: 37978195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of tumor antigens with immunopeptidomics.
    Chong C; Coukos G; Bassani-Sternberg M
    Nat Biotechnol; 2022 Feb; 40(2):175-188. PubMed ID: 34635837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery.
    Stutzmann C; Peng J; Wu Z; Savoie C; Sirois I; Thibault P; Wheeler AR; Caron E
    Cell Rep Methods; 2023 Jun; 3(6):100511. PubMed ID: 37426761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry Based Immunopeptidomics for the Discovery of Cancer Neoantigens.
    Bassani-Sternberg M
    Methods Mol Biol; 2018; 1719():209-221. PubMed ID: 29476514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.
    ElAbd H; Franke A
    Methods Mol Biol; 2024; 2758():425-443. PubMed ID: 38549028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry.
    Phulphagar KM; Ctortecka C; Jacome ASV; Klaeger S; Verzani EK; Hernandez GM; Udeshi ND; Clauser KR; Abelin JG; Carr SA
    Mol Cell Proteomics; 2023 Jun; 22(6):100563. PubMed ID: 37142057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
    Sirois I; Isabelle M; Duquette JD; Saab F; Caron E
    J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
    Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
    Front Immunol; 2018; 9():912. PubMed ID: 29780384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.
    Chong C; Müller M; Pak H; Harnett D; Huber F; Grun D; Leleu M; Auger A; Arnaud M; Stevenson BJ; Michaux J; Bilic I; Hirsekorn A; Calviello L; Simó-Riudalbas L; Planet E; Lubiński J; Bryśkiewicz M; Wiznerowicz M; Xenarios I; Zhang L; Trono D; Harari A; Ohler U; Coukos G; Bassani-Sternberg M
    Nat Commun; 2020 Mar; 11(1):1293. PubMed ID: 32157095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
    Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
    J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.
    Flad T; Spengler B; Kalbacher H; Brossart P; Baier D; Kaufmann R; Bold P; Metzger S; Blüggel M; Meyer HE; Kurz B; Müller CA
    Cancer Res; 1998 Dec; 58(24):5803-11. PubMed ID: 9865739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides.
    Bonté PE; Arribas YA; Merlotti A; Carrascal M; Zhang JV; Zueva E; Binder ZA; Alanio C; Goudot C; Amigorena S
    Cell Rep; 2022 Jun; 39(10):110916. PubMed ID: 35675780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
    Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
    Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
    Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
    Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen discovery for the development of cancer immunotherapy.
    Ahn R; Cui Y; White FM
    Semin Immunol; 2023 Mar; 66():101733. PubMed ID: 36841147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens.
    Khazan-Kost S; Cafri G; Melamed Kadosh D; Mooshayef N; Chatterji S; Dominissini D; Manor S; Zisser B; Broday L; Talalai E; Shemer A; Zadok O; Ofek E; Onn A; Admon A; Peled M
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma.
    Wahle M; Thielert M; Zwiebel M; Skowronek P; Zeng WF; Mann M
    Mol Cell Proteomics; 2024 Jan; 23(1):100689. PubMed ID: 38043703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of immunopeptidomics: From basic research to clinical implementation.
    Shapiro IE; Bassani-Sternberg M
    Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy.
    Minegishi Y; Haga Y; Ueda K
    Cancer Sci; 2024 Apr; 115(4):1048-1059. PubMed ID: 38382459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.